2015China Modern DoctorRequires access

The effect of valsartan combined with extended release nifedipine tablets in treatment of essential hypertension

Lin Shuxi

Open publisher page 0 citations

Abstract

Objective To explore the effect of valsartan and nifedipine sustained-release tablets in treatment of essential hypertension. Methods A total of 64 cases of primary hypertension patients were selected as the research object,according to the different treatment methods they were divided into group A and group B, 32 cases in each group.Group B was treated with oral nifedipine sustained-release tablets 20 mg, 1 times/d, group A combined with oral valsartan 40 mg, 1 times/d, continuous treatment for 4 weeks. The changes of SBP,DBP and the clinical curative effect of two groups were compared before and after treatment. Results SBP and DBP in group A and group B before the treatment had no significant difference between two groups(P0.05); After the treatment,SBP and DBP of group A were(118.42±14.82)mm Hg and(80.47±6.23) mm Hg, were significantly lower than group B, the difference was statistically significant between two groups(P0.05). After 4 weeks treatment, the efficiency of group A and group B were 53.12%,40.62%, total effectiveness of group A, group B respectively was 96.87%,71.87%, the effect of A group was higher than that of B group, with statistically significant difference(P0.05). Conclusion The combination of valsartan and nifedipine sustained-release tablets in treatment of primary hypertension have obvious effect, less adverse reaction, is worth the clinical promotion.

About this research paper

What this paper is about

Objective To explore the effect of valsartan and nifedipine sustained-release tablets in treatment of essential hypertension. Methods A total of 64 cases of primary hypertension patients were selected as the research object,according to the different treatment methods they were divided into group A and group B, 32 cases in each group.Group B was treated with oral nifedipine sustained-release tablets 20 mg, 1 times/d, group A combined with oral valsartan 40 mg, 1 times/d, continuous treatment for 4 weeks. The changes of SBP,DBP and the clinical curative effect of two groups were compared before and after treatment. Results SBP and DBP in group A and group B before the treatment had no significant difference between two groups(P0.05); After the treatment,SBP and DBP of group A were(118.42±14.82)mm Hg and(80.47±6.23) mm Hg, were significantly lower than group B, the difference was statistically significant between two groups(P0.05). After 4 weeks treatment, the efficiency of group A and group B were 53.12%,40.62%, total effectiveness of group A, group B respectively was 96.87%,71.87%, the effect of A group was higher than that of B group, with statistically significant difference(P0.05). Conclusion The combination of valsartan and nifedipine sustained-release tablets in treatment of primary hypertension have obvious effect, less adverse reaction, is worth the clinical promotion.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the effect of valsartan and nifedipine sustained-release tablets in treatment of essential hypertension. Methods A total of 64 cases of primary hypertension patients were selected as the research object,according to the different treatment methods they were divided into group A and group B, 32 cases in each group.Group B was treated with oral nifedipine sustained-release tablets 20 mg, 1 times/d, group A combined with oral valsartan 40 mg, 1 times/d, continuous treatment for 4 weeks. The changes of SBP,DBP and the clinical curative effect of two groups were compared before and after treatment. Results SBP and DBP in group A and group B before the treatment had no significant difference between two groups(P0.05); After the treatment,SBP and DBP of group A were(118.42±14.82)mm Hg and(80.47±6.23) mm Hg, were significantly lower than group B, the difference was statistically significant between two groups(P0.05). After 4 weeks treatment, the efficiency of group A and group B were 53.12%,40.62%, total effectiveness of group A, group B respectively was 96.87%,71.87%, the effect of A group was higher than that of B group, with statistically significant difference(P0.05). Conclusion The combination of valsartan and nifedipine sustained-release tablets in treatment of primary hypertension have obvious effect, less adverse reaction, is worth the clinical promotion.

Key concepts: Medicine, Nifedipine, Valsartan, Group B, Group A, Essential hypertension, Significant difference, Adverse effect

Related papers

Back to paper searchBrowse research topicsOriginal source
The effect of valsartan combined with extended release nifedipine tablets in treatment of essential hypertension — Research Paper | ScholarLens